The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
Linda Cardellini in "DTF St. Louis."
，这一点在同城约会中也有详细论述
Streaming Transcription (Nemotron 600M)
./build/parakeet model.safetensors audio.wav --vocab vocab.txt --gpu